Although the Supreme Court has recently increased its review of patent laws, the rulings have only eliminated deviations and reinforced precedent. However, the implications for nutraceutical companies is that their patent applications would have to represent a true invention and be very precise, rather than being a collection of scientific facts or trivial improvements. In his byline on www.nutraingredients-usa.com, Foley’s John Garvey discusses three recent cases reviewed by the Supreme Court and the impact of these decisions on dietary supplement and functional foods companies looking to patent their technologies.
Related Insights
22 January 2024
Events
Online Tracking Technologies: Implications under HIPAA and Beyond
Foley senior counsel Aaron Maguregui, co-chair of the firm’s Data Intelligence Area of Focus, is speaking at Business Research Intelligence Network’s Telehealth & Digital Healthcare Management Summit.
06 December 2023
The Path & The Practice
Podcast Episode 108: Rudhir Krishtel, CEO/Facilitator, Krishtel
This episode features special guest Rudhir Krishtel. In this conversation, Rudhir reflects on attending the University of Michigan for undergrad, earning his J.D. from the University of Maryland Francis King Carey School of Law, and practicing for a decade at Fish & Richardson as a patent litigation partner, before working in-house for Apple.
06 December 2023
Health Care Law Today
Decentralized Clinical Trials: Diversity in Clinical Trials
The U.S. Food and Drug Administration (FDA) has demonstrated a commitment to expanding diversity in clinical trials.